Natural solutions getting continually explored in drug improvement programs, attracting the consideration of scientific analysis efforts as a consequence of their pharmacophore-like structures, pharmacokinetic properties, and unique chemical space, the major pharma sector has focused on cutting-edge technologies that combine high-throughput screening and combinatory chemistry approaches to acquire and evaluate synthetic compound libraries (Henninot et al., 2018; Batool et al., 2019). This selection is, in component, a consequence in the complicated structures of all-natural merchandise that impose Adenosine A2A receptor (A2AR) Inhibitor Compound limitations in synthetic routes and because of the time-consuming and laborious method involved in the isolation of a single chemical constituent, which generally calls for a considerable amount of reagents and sufficient infrastructure, acquiring low yields of purified target compounds (Huffman and Shenvi, 2019). 5-HT Receptor Agonist Synonyms Determined by these limitations, the isolation and also the characterization of compounds from all-natural sources have been indicated only for all those with possible applications and desirable biological activities (Olivon et al., 2017). Having said that, it has been suggested that the reduced new chemical entities identified by the pharmaceutical market that attain the final market could possibly be as a result of strategic decision to prioritize combinatorial synthetic libraries as an alternative of all-natural product-based libraries (Over et al., 2013; Rodrigues, 2017). At the moment, we are witnessing a resurgence of natural products in the improvement and analysis of novel bioactive compounds; apart from, some structural scaffolds obtained from distinct classes of organic merchandise,Frontiers in Chemistry | www.frontiersin.orgApril 2021 | Volume 9 | ArticleSantana et al.Applications of Virtual Screening inside the Bioprospectingsuch as alkaloids, phenylpropanoids, polyketides, and terpenoids, have served as an inspiration to design new drug candidates (Thomford et al., 2018; Davison and Brimble, 2019; Gal io et al., 2019; Li et al., 2019). Natural solutions remain inspiring the improvement of new drugs, cosmetics, along with other bioactive compounds for human use (Newman and Cragg, 2020; Atanasov et al., 2021). Recently, metabolomics and metabolic profiling approaches have explored novel taxonomic groups in the one of a kind environment, giving possibilities for discovering novel all-natural bioactive compounds, and a few examples include bacteria (Kleigrewe et al., 2015; Gosse et al., 2019), cnidaria (Santacruz et al., 2020), marine sponge (Abdelhameed et al., 2020), insects (Klupczynska et al., 2020), and fungi (Oppong-Danquah et al., 2018). Specific focus has been given to novel chemical entities that originated from marine environments on account of their diverse and exclusive drug-like scaffolds (Shang et al., 2018) and physicochemical properties (Jagannathan, 2019) when compared with natural merchandise of terrestrial origin, which make them a valuable supply for exploration by the pharmaceutical and biotechnological industries. Advances inside the experimental strategies applied in metabolomic approaches coupled with computational solutions have been valuable to identifying new natural goods with plausible biological activities too as to understanding their molecular mechanisms of action (Atanasov et al., 2021). Currently, artificial intelligence algorithms (Wolfe et al., 2018; Lima et al., 2020; Stokes et al., 2020) and omics-based technologies (Floros et al., 2016; Huang et al., 2017; Jones and Bunnage, 2017; Merwin et al., 2020) have emerged as approaches to charac.